Phase I dose and sequencing study of peg
β
Paula M. Fracasso; Luis C. Rodriguez; Thomas J. Herzog; Carole L. Fears; Sherry
π
Article
π
2003
π
John Wiley and Sons
π
English
β 89 KB
π 1 views
## Abstract ## BACKGROUND Pegylated liposomal doxorubicin (PEGβLD) and docetaxel have singleβagent activity in several malignancies. The authors conducted a Phase I trial to evaluate the maximum tolerated dose (MTD), toxicities, and effect of dose sequencing of this combination in patients with ad